Edward Shanbrom

This inventor holds 50 USPTO granted patents and 1 published patent application, primarily in Blood Component Preservation (CPC class 4241). Top assignees: Shanbrom Technologies, LLC, Edward Shanbrom, Inc., American National Red Cross. Active years: 1976-2013.

USPTO Granted Patents = 50 (Patent Applications = 1)

% Patents Active = 86.0

Average Co-Inventor Count = 1.1

ph-index = 18

Forward Citations = 1,246(Granted Patents)

Forward Citations (Not Self Cited) = 1,195(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

22 out of 22

Shanbrom Technologies, LLC

patents

5 out of 5

Edward Shanbrom, Inc.

patents

1 out of 71

American National Red Cross

patents

4. 1 out of 8

Amersham Pharmacia Biotech, Inc.

Luther Medical Products, Inc.

Societe Anonyme Dite: Institut Merieux

patents

9. 1 out of 137

Societe Anonyme Dite: L'oreal

patents

10. 18 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1976-2013

Loading Chart...

Areas of Expertise:

Cryoprecipitate Extraction

Blood Clotting Factors

Microbicide Treated Materials

Antimicrobial Preservation

Disinfection Methods

Blood Plasma Antiviral

Iodinated Matrices

Protein Recovery

Tissue Culture Processes

Non-Thrombogenic Catheter

Antiviral Gel

Factor VIII Concentrate

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8389687 - Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors (2013-03-05),

2. 8003706 - Enhanced production of blood clotting factors and fibrin fabric (2011-08-23),

3. 7411006 - Enhanced production of blood clotting factors and fibrin fabric (2008-08-12),

4. 7297716 - Enhanced production of blood components, blood cells and plasma without freezing (2007-11-20),

5. 6881731 - Enhancers for microbiological disinfection (2005-04-19),

6. 6863905 - Enhanced iodine treatment of drinking water (2005-03-08),

7. 6841060 - Method for quantifying antioxidant levels in food and medical specimens (2005-01-11),

8. 6821533 - Antimicrobial lees (2004-11-23),

9. 6610316 - Disinfection by particle-bound and insolubilized detergents (2003-08-26),

10. 6548076 - Antimicrobial lees (2003-04-15),

11. 6541518 - Enhanced production of safe plasma preparations (2003-04-01),

12. 6361786 - Microbicide treated polymeric materials (2002-03-26),

13. 6183764 - Microbicide treated polymeric materials (2001-02-06),

14. 6096216 - Iodinated matrices for disinfecting biological fluids (2000-08-01),

15. 6093401 - Natural color concentrates and antimicrobial nutraceutial from plants (2000-07-25),

Title: Edward Shanbrom: Innovating in Blood Clotting Factor Extraction

Introduction

Edward Shanbrom, a prominent inventor based in Santa Ana, CA, holds an impressive portfolio of 50 patents. His work focuses on advancements in blood collection and processing, particularly in improving the extraction of clotting factors. This article delves into his latest patents, career highlights, and collaborations.

Latest Patents

Among Shanbrom's notable innovations are his patents related to the extraction of blood clotting factors using polyvinylpyrrolidone. His patented methods enhance the yield and purity of cryoprecipitate by optimizing the citrate concentration during blood processing. This innovative process significantly improves the safety and efficacy of end products by inhibiting the activation of blood components, making it particularly effective for use with single donors or limited pools. Additionally, the remaining cryoprecipitate can be transformed into a fibrin fabric, which is beneficial for surgical applications and wound treatment.

Career Highlights

Shanbrom Technologies, LLC, stands as a testament to Edward Shanbrom's dedication to advancing medical technologies. His work has led to breakthroughs in the field of blood processing, demonstrating a commitment to innovation that enhances patient care. With 50 patents to his name, Shanbrom has made significant contributions to medical technology.

Collaborations

Throughout his career, Edward Shanbrom has collaborated with noted professionals such as Robert C. Bishop and Jacques C. Liautaud. These partnerships have played a crucial role in developing his patented technologies, further cementing his reputation as a leader in his field.

Conclusion

Edward Shanbrom continues to be a pivotal figure in the innovation of blood clotting factor extraction. His latest patents highlight his commitment to improving medical processes and patient outcomes. Through his work, Shanbrom not only advances technology but also contributes to the broader field of medicine, making a lasting impact on healthcare.